SCHEDULE 13G

Company

Travere Therapeutics, Inc.

Filed

March 31, 2016

Accession Number

0000891092-16-013889

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →